María del Carmen Cruz
Instituto Politécnico Nacional
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by María del Carmen Cruz.
Bioorganic & Medicinal Chemistry | 2010
Nancy Argüelles; Eugenia Sánchez-Sandoval; Aarón Mendieta; Lourdes Villa-Tanaca; Leticia Garduño-Siciliano; Fabiola Jiménez; María del Carmen Cruz; José L. Medina-Franco; Germán Chamorro-Cevallos; Joaquín Tamariz
A series of alpha-asarone-based analogues was designed by conducting docking experiments with published crystal structures of human HMG-CoA reductase. Indeed, synthesis and evaluation of this series showed a highly hypocholesterolemic in vivo activity in a murine model, as predicted by previous docking studies. In agreement with this model, the polar groups attached to the benzene ring could play a key role in the enzyme binding and probably also in its biological activity, mimicking the HMG-moiety of the natural substrate. The hypolipidemic action mechanism of these compounds was investigated by developing a simple, efficient, and novel model for determining HMG-CoA reductase inhibition. The partial purification of the enzyme from Schizosaccharomyces pombe allowed for testing of alpha-asarone- and fibrate-based analogues, resulting in positive and significant inhibitory activity.
Pure and Applied Chemistry | 2007
Carlos González-Romero; Pablo Bernal; Fabiola Jiménez; María del Carmen Cruz; Aydeé Fuentes-Benítes; Adriana Benavides; Rafael Bautista; Joaquín Tamariz
The synthetic application of 4,5-bis-alkylidene-1,3-oxazolidin-2-ones led to the efficient and regioselective synthesis of 2-(3H)-benzoxazolones and diarylamines with a short methodology. They were also valuable synthons in a total synthesis of naturally occurring carbazoles. New enantiopure 4-oxazoline-2-one and 4-methylene-2-oxazolidinone were prepared via a one-pot microwave (MW)-promoted condensation of α-ketols and an enantiopure isocyanate. These enamides were efficient nucleophiles when added to Michael acceptors to give a series of compounds with quaternary stereocenters in fairly good stereoisomeric ratios. The novel approach for the synthesis of benzofurans and indoles by intramolecular cyclization of enaminones has been applied in the preparation of furobenzofurans starting from benzo-bis-enaminones.
Australian Journal of Chemistry | 2008
Christian Correa; María del Carmen Cruz; Fabiola Jiménez; L. Gerardo Zepeda; Joaquín Tamariz
The Lewis acid-catalyzed cyclization of the (Z)-3-(dimethylamino)-2-aryloxy-1-arylprop-2-en-1-ones 4a–h leads to a regioselective and short synthesis of 2-aroylbenzofurans 2a–h. The Wolff–Kishner reduction of the latter yielded a series of substituted 2-benzylbenzofurans 3a–h. This methodology was applied in the first total synthesis of the metabolite 2-(4-hydroxybenzyl)-6-methoxybenzofuran 1, which was isolated from the tropical plant Dorstenia gigas, and obtained through a six-step route and in a 24% overall yield.
Bioorganic & Medicinal Chemistry | 2014
Aarón Mendieta; Fabiola Jiménez; Leticia Garduño-Siciliano; Angélica Mojica-Villegas; Blanca Rosales-Acosta; Lourdes Villa-Tanaca; Germán Chamorro-Cevallos; José L. Medina-Franco; Nathalie Meurice; Rsuini U. Gutiérrez; Luisa E. Montiel; María del Carmen Cruz; Joaquín Tamariz
In the search for new potential hypolipidemic agents, the present study focused on the synthesis of 2-acyl phenols (6a-c and 7a-c) and their saturated side-chain alkyl phenols (4a-c and 5a-c), and on the evaluation of their hypolipidemic activity using a murine Tyloxapol-induced hyperlipidemic protocol. The whole series of compounds 4-7 greatly and significantly reduced elevated serum levels of total cholesterol, LDL-cholesterol, and triglycerides, with series 6 and 7 showing the greatest potency ever found in our laboratory. At the minimum dose (25mg/kg/day), the latter compounds lowered cholesterol by 68-81%, LDL by 72-86%, and triglycerides by 59-80%. This represents a comparable performance than that shown by simvastatin. Experimental evidence and docking studies suggest that the activity of these derivatives is associated with the inhibition of HMG-CoA reductase.
Tetrahedron Letters | 2004
María del Carmen Cruz; Joaquín Tamariz
Helvetica Chimica Acta | 2011
Alberto V. Jerezano; Fabiola Jiménez; María del Carmen Cruz; Luisa E. Montiel; Francisco Delgado; Joaquín Tamariz
Tetrahedron | 2005
María del Carmen Cruz; Joaquín Tamariz
Drug Development Research | 2005
Clara Zúñiga; Leticia Garduño; María del Carmen Cruz; María Salazar; Ricardo Pérez-Pastén; Germán Chamorro; Fernando Labarrios; Joaquín Tamariz
Drug Development Research | 2003
María del Carmen Cruz; María Salazar; Yésica Garciafigueroa; Dolores Hernández; Francisco Díaz; Germán Chamorro; Joaquín Tamariz
Natural Product Communications | 2013
Pazos Dc; Fabiola Jiménez; Garduño L; López Ve; María del Carmen Cruz